Glucose metabolism disease

Related records

Broader conditions (4)

• Disease
• Disease by developmental or physiological process
• Human disease
• Metabolic disease

Narrower conditions (91)

• Adult-onset non-insulinoma persistent hyperinsulinemic hypoglycemia
• Autosomal dominant hyperinsulinism due to Kir6.2 deficiency
• Autosomal dominant hyperinsulinism due to SUR1 deficiency
• Autosomal recessive hyperinsulinism due to Kir6.2 deficiency
• Autosomal recessive hyperinsulinism due to SUR1 deficiency
• Congenital isolated hyperinsulinism
• Cystic fibrosis-related diabetes
• DEND syndrome
• Developmental delay, epilepsy, and neonatal diabetes 1
• Developmental delay, epilepsy, and neonatal diabetes 2
• Diabetes mellitus
• Diabetes mellitus, noninsulin-dependent, 1
• Diabetes mellitus, noninsulin-dependent, 2
• Diabetes mellitus, noninsulin-dependent, 3
• Diabetes mellitus, noninsulin-dependent, 4
• Diabetes mellitus, noninsulin-dependent, 5
• Diabetes mellitus, permanent neonatal 2
• Diabetes mellitus, permanent neonatal 3
• Diabetes mellitus, permanent neonatal 4
• Diabetes mellitus, transient neonatal, 1

Trials (410)

• 1-hour Post-load Hyperglycemia and Mild Cognitive Impairment
• A Decentralized Study on Dietary Influences on Cognitive Functions
• A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.
• A Nutrient Cocktail to Protect Against Physical Inactivity
• A Pharmacokinetic Study of MK-3102 in Participants With Impaired Hepatic Function (MK-3102-031)
• A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
• A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus
• A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532
• A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
• A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
• A Study of LY2189265 in Japanese Patients With Type 2 Diabetes
• A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants
• A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)
• A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)
• A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
• A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)
• A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia

Other linked drugs (2)

• Dapagliflozin
• Saxagliptin